Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMI

A.H. Tavenier, R.S. Hermanides*, E. Fabris, D.J. Angiolillo, A.W.J. van't Hof

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)40-45
Number of pages6
JournalInternational Journal of Cardiology
Volume328
DOIs
Publication statusPublished - 1 Apr 2021

Keywords

  • Antiplatelet therapy
  • STEMI
  • Glycoprotein IIb
  • IIIa inhibitors
  • ST-SEGMENT-ELEVATION
  • PERCUTANEOUS CORONARY INTERVENTION
  • GLYCOPROTEIN IIB/IIIA INHIBITORS
  • MYOCARDIAL-INFARCTION PATIENTS
  • LONG-TERM MORTALITY
  • HIGH-DOSE TIROFIBAN
  • PRIMARY PCI
  • PREHOSPITAL TICAGRELOR
  • ANTIPLATELET ACTION
  • TASK-FORCE

Cite this